Abstract:Cellular senescence is a major contributor to aging-related degenerative diseases, including Alzheimer's disease (AD) but much less is known on the key cell types and pathways driving mechanisms of senescence in the brain. We hypothesized that dysregulated cholesterol metabolism is central to cellular senescence in AD. We analyzed whole transcriptomic data and utilized single-cell RNA seq integration techniques to unveil the convoluted cell-type-specific and sub-cell-type-state-specific senescence pathologies in AD using both ROSMAP and Sea-AD datasets. We identified that microglia are central components to AD associated senescence phenotypes in ROSMAP snRNA-seq data (982,384 nuclei from postmortem prefrontal cortex of 239 AD and 188 non-AD) among non-neuron cell types. We identified that homeostatic, inflammatory, phagocytic, lipid processing and neuronal surveillance microglia states were associated with AD associated senescence in ROSMAP (152,459 microglia nuclei from six regions of brain tissue of 138 early AD, 79 late AD and 226 control subject) and in Sea-AD (82,486 microglia nuclei of 42 dementia, 42 no dementia and 5 reference subjects) via integrative analysis, which preserves the meaningful biological information of microglia cell states across the datasets. We assessed top senescence associated bioprocesses including mitochondrial, apoptosis, oxidative stress, ER stress, endosomes, and lysosomes systems. Specifically, we found that senescent microglia have altered cholesterol related bioprocesses and dysregulated cholesterol. We discovered three gene co-expression modules, which represent the specific cholesterol related senescence transcriptomic signatures in postmortem brains. To validate these findings, the activation of specific cholesterol associated senescence transcriptomic signatures was assessed using integrative analysis of snRNA-seq data from iMGs (microglia induced from iPSCs) exposed to myelin, Abeta, and synaptosomes (56,454 microglia across two replicates of untreated and four treated groups). In vivo cholesterol associated senescence transcriptomic signatures were preserved and altered after treatment with AD pathological substrates in iMGs. This study provides the first evidence that dysregulation of cholesterol metabolism in microglia is a major driver of senescence pathologies in AD. Targeting cholesterol pathways in senescent microglia is an attractive strategy to slow down AD progression.

Is microglial dystrophy a form of cellular senescence? An analysis of senescence markers in the aged human brain

Microglia Impede Oligodendrocyte Generation in Aged Brain

Microglial cell dysregulation in brain aging and neurodegeneration

Untangling senescent and damage‐associated microglia in the aging and diseased brain

Microglia in the Aging Brain: Relevance to Neurodegeneration

Age-dependent Microglial Disease Phenotype Results in Functional Decline in Gut Macrophages

Microglia in the aging retina

Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer's disease

Microglial Dysfunction in Brain Aging and Neurodegeneration

Senescent glia link mitochondrial dysfunction and lipid accumulation

Chemically induced senescence prompts functional changes in human microglia-like cells

Old Maids: Aging and Its Impact on Microglia Function

Aged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods

Microglia Phenotypes Converge in Aging and Neurodegenerative Disease

Senescence and aging differentially alter key metabolic pathways in murine brain microglia

Exploring the link between dystrophic microglia and the spread of Alzheimer's neuropathology

Microglia States are Susceptible to Senescence and Cholesterol Dysregulation in Alzheimer's Disease

Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities

Microglia aging in the hippocampus advances through intermediate states that drive inflammatory activation and cognitive decline

Microglia Priming with Aging and Stress

Microglia change from a reactive to an age-like phenotype with the time in culture